August 07, 2020 - Pfizer Inc. (New York, NY) announced a multi-year agreement with Gilead Sciences, Inc. to manufacture and supply Gilead’s investigational antiviral remdesivir, as one of multiple external manufacturing organizations supporting efforts to scale up supply of the investigational treatment for COVID-19. Under the terms of the agreement, Pfizer will provide … [Read more...]
OraSure announces progress on new COVID-19 testing products
August 06, 2020 - OraSure (Bethlehem, PA) along with its quarterly financial results, announced what the company is doing to help the industry combat the COVID-19 pandemic. The company says it is well positioned to support multiple modes for COVID-19 testing, including PCR/molecular, antigen, and antibody testing. To support capacity building for the company’s existing … [Read more...]
Premier: Telehealth sees record usage, increasing 149x during first wave
August 06, 2020 - Virtual visits to ambulatory settings hit record usage during the first wave of the COVID-19 pandemic, increasing 149X in aggregate between March and May, compared to the prior nine-month, pre-pandemic weekly average, reports Premier Inc (Charlotte, NC). While the sudden uptake of virtual visits cooled off slightly as the first surge waned, ambulatory … [Read more...]
Premier, Somerset Pharma partner to stabilize pricing, enhance competition for antibiotic used to treat respiratory infections
August 04, 2020 - Premier Inc. (Charlotte, NC), through its ProvideGx program, has partnered with Somerset Pharma, LLC., to supply sulfamethoxazole/trimethoprim, an antibiotic combination used to treat respiratory infections, a common complication associated with COVID-19. Somerset is a new market entrant for this drug, working to creating a viable, competitive alternative … [Read more...]
Premier Inc: “Five Reasons Health Systems are Prioritizing Integration with Specialists”
August 03, 2020 - “Specialists and health systems have played a symbiotic role in the U.S. healthcare system for years, but in the months leading up to the onset of COVID-19, that symbiosis was starting to fracture due to shifting market dynamics, greater payer focus on non-hospital based care and disruptors. “Specialists have long depended on health systems for patient … [Read more...]
Sanofi, GSK selected for Operation Warp Speed to supply U.S. government with 100 million doses of COVID-19 vaccine
July 31, 2020 – Sanofi (Paris, France) and GSK (London, UK) announced a collaborative effort with the U.S. government to accelerate the development and manufacturing of a COVID-19 recombinant protein-based vaccine. The vaccine candidate, developed by Sanofi in partnership with GSK, is based on the recombinant protein-based technology used by Sanofi to produce an influenza … [Read more...]
Pfizer, BioNTech to supply Japan with 120 million doses of MRNA-based COVID-19 vaccine candidate
July 31, 2020 – Pfizer (New York, NY) and BioNTech SE (Germany) announced an agreement with the Ministry of Health, Labour and Welfare (MHLW) in Japan to supply 120 million doses of BNT162 mRNA-based vaccine candidate against SARS-CoV2 (the virus that causes COVID-19), subject to clinical success and regulatory approval, beginning in 2021. Financial details of the … [Read more...]
BD announces $24M U.S. government investment to support scale up of U.S. manufacturing of COVID-19 diagnostic tests
July 31, 2020 – BD (Becton, Dickinson and Company) (Franklin Lakes, NJ) announced a $24 million investment from the U.S. Department of Defense (DOD) in collaboration with the U.S. Department of Health and Human Services (HHS) to support the scale up of U.S. manufacturing capabilities for BD Veritor Solution for Rapid Detection of SARS-CoV-2 (the virus that causes … [Read more...]
Premier: Statement for the Record on the Senate Finance Committee Hearing on Protecting the Reliability of the U.S. Medical Supply Chain During COVID-19
July 31, 2020 – “In a statement for the record for the Senate Finance Committee hearing on protecting the reliability of the U.S. medical supply chain during the COVID-19 pandemic, Premier underscores how the existing private sector supply chain can be further enabled and augmented to prevent gaps in vital medical supplies to address future pandemics. "To help strengthen … [Read more...]
Vizient supply chain expert Cathy Denning to participate in Senate Finance Committee Hearing on counterfeit PPE
July 30, 2020 – Vizient, Inc. (Irving, TX) announced that Cathy Denning, a sourcing and supply chain expert, is testifying before the U.S. Senate Committee on Finance during the second part of its hearing, “Protecting the Reliability of the U.S. Medical Supply Chain During the COVID-19 Pandemic.” Denning, RN, MSN, group SVP of sourcing operations, analytics and center of … [Read more...]